Testing the Efficacy of A Scalable, Telephone-Delivered, Guided Imagery Tobacco Cessation Intervention
Primary Purpose
Smoking Cessation, Smoking, Smoking Reduction
Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Guided Imagery Intervention
Standard Behavioral Control
Sponsored by
About this trial
This is an interventional treatment trial for Smoking Cessation
Eligibility Criteria
Inclusion Criteria:
- Report daily smoking in the last 30 days
- Age 18 or over
- Speak English
- Have a smart phone with internet access
- Willing to receive coaching over the phone
Exclusion Criteria:
- No phone
- No internet access
- Does not speak English
- More than one person per household
- Psychosis
Sites / Locations
- University of ArizonaRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Guided Imagery Intervention
Standard Behavioral Control
Arm Description
Guided Imagery Intervention
Standard Behavioral Control
Outcomes
Primary Outcome Measures
Number of participants who achieve biochemically verified 7 day smoking abstinence
Smoking abstinence will be biochemically verified with expired carbon monoxide
Secondary Outcome Measures
Number of participants who report 7 day smoking abstinence
Participants will self-report tobacco use
Number of participants who report 30 day smoking abstinence
Participants will self-report tobacco use
Number of minutes of intervention use per week
Number of minutes participants engage in study sessions per week
Number of minutes guided imagery and other integrative skills practiced per day
Participants will self-report number of minutes guided imagery and other integrative skills practiced per day for the past 7 days
Number of intervention sessions attended
Full Information
NCT ID
NCT05277831
First Posted
February 14, 2022
Last Updated
September 7, 2023
Sponsor
University of Arizona
Collaborators
National Center for Complementary and Integrative Health (NCCIH)
1. Study Identification
Unique Protocol Identification Number
NCT05277831
Brief Title
Testing the Efficacy of A Scalable, Telephone-Delivered, Guided Imagery Tobacco Cessation Intervention
Official Title
Testing the Efficacy of A Scalable, Telephone-Delivered, Guided Imagery Tobacco Cessation Intervention
Study Type
Interventional
2. Study Status
Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
August 1, 2022 (Actual)
Primary Completion Date
August 31, 2026 (Anticipated)
Study Completion Date
August 31, 2026 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Arizona
Collaborators
National Center for Complementary and Integrative Health (NCCIH)
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The objective of this R01 application is to conduct a randomized controlled trial to test the efficacy of the Be Smoke Free, telephone-based, guided imagery (GI) intervention (IC) for smoking cessation compared to active behavioral control (CC). The study will recruit 1,200 diverse smokers from three states, Arizona, New York, and West Virginia to increase generalizability. Participants will be randomly assigned to receive either the IC or CC delivered by telephone by University of Arizona study coaches and will be assessed at 3- and 6-months post-enrollment by study staff. The primary outcome is biochemically verified 7-day point prevalence abstinence at 6 months. This innovative and rigorously designed project conducted by an experienced team has the potential to improve public health through the delivery of an innovative integrative GI intervention via telephone.
Detailed Description
The Specific Aims of the proposed study are to:
Aim 1: Test the efficacy of a telephone-delivered, integrative GI tobacco cessation intervention (IC) vs. an active behavioral control (CC) on biochemically verified 7-day point prevalence and self-reported 30-day smoking abstinence at 6 months post-enrollment. Four weeks of nicotine replacement therapy (NRT) will be included in both conditions. The investigators will assess self-reported 7-day and 30-day tobacco use at baseline, and 3- and 6-months post-enrollment. Our primary outcome is biochemically verified 7-day point prevalence abstinence at 6 months using the Smokerlyzer iCO expired CO monitor.
H1: Participants in the IC will have 10% higher quit rates than those in the CC. A 10% increase is clinically meaningful on a population level. A sample size of 1200 will provide 90% power to detect a 10% increase over a control condition quit rate of 30% with 20% missing data.
Aim 2: Conduct dose-response analyses on the effect of IC adherence (measured by self-reported minutes of intervention use per week, number of times GI skills practiced per weeks, number of sessions attended, and coach-rated participant engagement in sessions) on abstinence at 6 months. The investigators will also examine effects of the IC and CC on tobacco use for those participants who do not report abstinence at 6-months.
H2A: IC participants who are more adherent will have higher rates of biochemically verified abstinence.
H2B: IC and CC participants who do not report abstinence will report significant reductions in tobacco use.
Aim 3: Conduct subgroup analyses of moderators (e.g., phone type/plan, recruitment method, location, sex, race/ethnicity, level of dependence) on tobacco cessation outcomes at 6 months, and assess participants using a mixed-methods approach (e.g., surveys, in-depth interviews) for exploring sub-group differences. This innovative and rigorously designed project conducted by an experienced team has the potential to improve public health through the delivery of an innovative integrative GI intervention via telephone. If successful, this intervention model could be expanded to address other forms of tobacco and e-cigarettes.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Smoking Cessation, Smoking, Smoking Reduction, Smoking, Cigarette, Smoking (Tobacco) Addiction, Smoking Habit
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1200 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Guided Imagery Intervention
Arm Type
Experimental
Arm Description
Guided Imagery Intervention
Arm Title
Standard Behavioral Control
Arm Type
Active Comparator
Arm Description
Standard Behavioral Control
Intervention Type
Other
Intervention Name(s)
Guided Imagery Intervention
Intervention Description
Participants in the Guided Imagery Intervention receive 6 sessions of a Guided Imagery plus standard smoking cessation coaching over 6 weeks, delivered by telephone. Sessions range from 10 - 60 minutes, and cover reasons for and benefits of quitting, triggers and alternative strategies, coping with cravings, withdrawal and NRT, and relapse prevention. In each session, coaches work with participants to create or revise guided imagery scripts. After the session, coaches record the script as a digital audio file and send to the participant. Participants listen to their audio file every day and practice behavioral skills between sessions.
Intervention Type
Other
Intervention Name(s)
Standard Behavioral Control
Intervention Description
Participants in the Standard Behavioral Control condition receive 6 sessions of a standard smoking cessation coaching over 6 weeks, delivered by telephone. Sessions range from 10 - 60 minutes, and cover reasons for and benefits of quitting, triggers and alternative strategies, coping with cravings, withdrawal and NRT, and relapse prevention. In each session, coaches work with participants to identify lifestyle changes to support tobacco cessation, and set a schedule for practicing new behavioral strategies. Participants complete exercises in a quit booklet every day and practice behavioral skills between sessions.
Primary Outcome Measure Information:
Title
Number of participants who achieve biochemically verified 7 day smoking abstinence
Description
Smoking abstinence will be biochemically verified with expired carbon monoxide
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Number of participants who report 7 day smoking abstinence
Description
Participants will self-report tobacco use
Time Frame
Baseline, 3 months, and 6 months
Title
Number of participants who report 30 day smoking abstinence
Description
Participants will self-report tobacco use
Time Frame
Baseline, 3 months, and 6 months
Title
Number of minutes of intervention use per week
Description
Number of minutes participants engage in study sessions per week
Time Frame
Week 1, Week 2, Week 3, Week 4, Week 5, Week 6
Title
Number of minutes guided imagery and other integrative skills practiced per day
Description
Participants will self-report number of minutes guided imagery and other integrative skills practiced per day for the past 7 days
Time Frame
3 months, 6 months
Title
Number of intervention sessions attended
Time Frame
Week 1, Week 2, Week 3, Week 4, Week 5, Week 6
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Report daily smoking in the last 30 days
Age 18 or over
Speak English
Have a smart phone with internet access
Willing to receive coaching over the phone
Exclusion Criteria:
No phone
No internet access
Does not speak English
More than one person per household
Psychosis
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Judith S Gordon, PhD
Phone
520-626-4970
Email
judithg@arizona.edu
Facility Information:
Facility Name
University of Arizona
City
Tucson
State/Province
Arizona
ZIP/Postal Code
85714
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kari MK Marano, MPH, CHES
Phone
520-626-9274
Email
besmokeefree@arizona.edu
First Name & Middle Initial & Last Name & Degree
Judith S Gordon, PhD
12. IPD Sharing Statement
Learn more about this trial
Testing the Efficacy of A Scalable, Telephone-Delivered, Guided Imagery Tobacco Cessation Intervention
We'll reach out to this number within 24 hrs